[Dermatologic study of a new ointment: Dexatopic].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001645:Biguanides / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003872:Dermatitis / Q000188:drug therapy; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003907:Dexamethasone / Q000008:administration & dosage*; D004485:Eczema / Q000188:drug therapy; D011146:Eczema, Dyshidrotic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000008:administration & dosage*; D009450:Neurodermatitis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D001645:Biguanides; D009277:Nandrolone; D003907:Dexamethasone
Etude dermatologique d'une nouvelle crème: le Dexatopic.